Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

Using Radiogenomics to Predict Malignant Potential of Intraductal Papillary Mucinous Neoplasms of the Pancreas

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT04275557
Recruitment Status : Recruiting
First Posted : February 19, 2020
Last Update Posted : June 3, 2021
Sponsor:
Collaborators:
National Cancer Institute (NCI)
University of Florida
University of Miami
Information provided by (Responsible Party):
H. Lee Moffitt Cancer Center and Research Institute

No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : Recruiting
Estimated Primary Completion Date : February 2025
Estimated Study Completion Date : February 2027